Insider · CIK 0000940805
Norman D Schwartz
Files at BIO (BIO-RAD LABORATORIES, INC.). First filing -, latest -.
Norman D Schwartz files SEC Form 4 as CEO, chair, director and 10% owner at BIO (BIO-RAD LABORATORIES, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Norman D Schwartz has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 21 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 5, 2026 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Bio-Rad A Common Stock | +4,109 | $0.00 | $0 | 450,294 | 34 d ago |
| Sep 5, 2026 | BIO BIO-RAD LABORATORIES, INC. | FTax withholding Bio-Rad A Common Stock | -2,876 | $386.11 | $1.1M | 447,418 | 34 d ago |
| Sep 6, 2026 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Bio-Rad A Common Stock | +3,455 | $0.00 | $0 | 450,873 | 34 d ago |
| Sep 6, 2026 | BIO BIO-RAD LABORATORIES, INC. | FTax withholding Bio-Rad A Common Stock | -1,854 | $386.11 | $716k | 449,019 | 34 d ago |
| Sep 4, 2026 | BIO BIO-RAD LABORATORIES, INC. | AGrant or award Restricted Stock Unitsderivative | +17,251 | $0.00 | $0 | 17,251 | 34 d ago |
| Sep 5, 2026 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -4,109 | $0.00 | $0 | 12,330 | 34 d ago |
| Sep 6, 2026 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -3,455 | $0.00 | $0 | 6,912 | 34 d ago |
| Sep 1, 2026 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Bio-Rad A Common Stock | +5,087 | $0.00 | $0 | 448,521 | 40 d ago |
| Sep 1, 2026 | BIO BIO-RAD LABORATORIES, INC. | FTax withholding Bio-Rad A Common Stock | -2,336 | $380.96 | $890k | 446,185 | 40 d ago |
| Sep 1, 2026 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -2,082 | $0.00 | $0 | 0 | 40 d ago |
| Sep 1, 2026 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -3,005 | $0.00 | $0 | 3,005 | 40 d ago |
| Sep 6, 2025 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Bio-Rad A Common Stock | +3,455 | $0.00 | $0 | 444,962 | Sep 9, 2025 |
| Sep 6, 2025 | BIO BIO-RAD LABORATORIES, INC. | FTax withholding Bio-Rad A Common Stock | -1,528 | $295.43 | $451k | 443,434 | Sep 9, 2025 |
| Sep 5, 2025 | BIO BIO-RAD LABORATORIES, INC. | AGrant or award Restricted Stock Unitsderivative | +16,439 | $0.00 | $0 | 16,439 | Sep 9, 2025 |
| Sep 6, 2025 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -3,455 | $0.00 | $0 | 10,367 | Sep 9, 2025 |
| Sep 1, 2025 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Bio-Rad A Common Stock | +6,353 | $0.00 | $0 | 444,591 | Sep 3, 2025 |
| Sep 1, 2025 | BIO BIO-RAD LABORATORIES, INC. | FTax withholding Bio-Rad A Common Stock | -3,084 | $297.88 | $919k | 441,507 | Sep 3, 2025 |
| Sep 1, 2025 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -1,266 | $0.00 | $0 | 0 | Sep 3, 2025 |
| Sep 1, 2025 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -2,082 | $0.00 | $0 | 2,082 | Sep 3, 2025 |
| Sep 1, 2025 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -3,005 | $0.00 | $0 | 6,010 | Sep 3, 2025 |
| Mar 3, 2025 | BIO BIO-RAD LABORATORIES, INC. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +11,671 | $0.00 | $0 | 11,671 | Mar 5, 2025 |
Questions about Norman D Schwartz
Answered from the filings on this page, as of the latest one.
Is Norman D Schwartz buying or selling?
Norman D Schwartz has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Norman D Schwartz's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Norman D Schwartz has 0.
Where does Norman D Schwartz file Form 4?
Norman D Schwartz has filed Form 4 at BIO (BIO-RAD LABORATORIES, INC.) as Chairman & CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.